Is XBOTF or MRK a better dividend investment in 2026?

XBOTF currently yields 938.97% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: XBOTF offers higher current income.

What is the dividend yield difference between XBOTF and MRK?

XBOTF has a forward dividend yield of 938.97% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 936.21 percentage points.

Home › Compare › XBOTF vs MRK

XBOTF vs MRK: Dividend Comparison 2026

XBOTF yields 938.97% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XBOTF wins by $10907833.65M in total portfolio value

INVESTMENT

TIME HORIZON10 years

XBOTF

● Live price

938.97%

Share price

$0.21

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$10907833.71M

Annual income

$9,018,453,164,273.55

Full XBOTF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — XBOTF vs MRK

📍 XBOTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XBOTF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XBOTF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XBOTF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBOTF

Annual income on $10K today (after 15% tax)

$79,812.21/yr

After 10yr DRIP, annual income (after tax)

$7,665,685,189,632.52/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, XBOTF beats the other by $7,665,685,181,304.11/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBOTF + MRK for your $10,000?

XBOTF: 50%MRK: 50%

100% MRK50/50100% XBOTF

Portfolio after 10yr

$5453916.88M

Annual income

$4,509,226,587,035.85/yr

Blended yield

82.68%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

XBOTF

No analyst data

Altman Z

13.2

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBOTF buys

MRK buys

No recent congressional trades found for XBOTF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXBOTFMRK

Forward yield	938.97% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$10907833.71M ✓	$56.8K
Annual income after 10y	$9,018,453,164,273.55 ✓	$9,798.13
Total dividends collected	$10762152.60M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: XBOTF vs MRK ($10,000, DRIP)

Year	XBOTF Portfolio	XBOTF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$104,597	$93,896.71	$11,206	$366.19	+$93.4K → XBOTF
2	$1,029,796	$917,877.35	$12,650	$502.35	+$1.02M → XBOTF
3	$9,547,549	$8,445,667.27	$14,407	$694.19	+$9.53M → XBOTF
4	$83,395,632	$73,179,754.27	$16,585	$967.82	+$83.38M → XBOTF
5	$686,624,199	$597,390,873.08	$19,342	$1,363.89	+$686.60M → XBOTF
6	$5,331,434,975	$4,596,747,082.06	$22,913	$1,947.19	+$5331.41M → XBOTF
7	$39,062,008,542	$33,357,373,119.48	$27,662	$2,823.89	+$39061.98M → XBOTF
8	$270,208,140,101	$228,411,790,960.80	$34,159	$4,173.35	+$270208.11M → XBOTF
9	$1,765,776,209,124	$1,476,653,499,216.14	$43,337	$6,308.80	+$1765776.17M → XBOTF
10	$10,907,833,708,037	$9,018,453,164,273.55	$56,776	$9,798.13	+$10907833.65M → XBOTF

XBOTF vs MRK: Complete Analysis 2026

XBOTF — Stock

Realbotix Corp. develops customizable human-like robots with artificial intelligence integration in Canada. The company operates through Staking, Metaverse Services, Play-To-Earn Gaming, and Consumer Products segments. It offers crypto staking, metaverse strategy services, environment development services, digital land rental, partnerships, fungible and non-fungible tokens, and robotics products, as well as operates proof-of-stake technology to secure next generation blockchain networks. The company was formerly known as Tokens.com Corp. and changed its name to Realbotix Corp. in July 2024. Realbotix Corp. is based in Toronto, Canada.

Full XBOTF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this XBOTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBOTF vs SCHD XBOTF vs JEPI XBOTF vs O XBOTF vs KO XBOTF vs MAIN XBOTF vs JNJ XBOTF vs ABBV XBOTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.